-
Aug 31, 2020, 09:45
by
User Not Found
Clinical Research News | The COVID-19 pandemic has forced clinical trial sponsors and sites to think outside the box, offering innovative services to help patient recruitment, sample collection, and other phases of clinical research. There’s also another voice that needs to be considered: namely, that of the patient.
Full story
-
Aug 28, 2020, 10:18
by
User Not Found
Clinical Research News | Recommendations for COVID-19 rehabilitation, four months of data from Italy’s use of hydroxychloroquine, more data on which comorbidities are most dangerous, Remdesivir data, and more on imaging. Plus, research grants and a convalescent plasma architecture.
Full story
-
Aug 26, 2020, 01:00
by
User Not Found
Clinical Research News| The pandemic has deepened the disconnect with healthcare providers for patients with chronic conditions by reducing the frequency of in-person encounters while heightening patients’ anxiety about how to self-manage and access trusted health advice when they need it. Pack Health specializes in digital health coaching for just such scenarios.
Full story
-
Aug 24, 2020, 16:26
by
User Not Found
Clinical Research News | August was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Caris, Thermo Fisher Scientific, and more.
Full story
-
Aug 21, 2020, 01:00
by
User Not Found
Clinical Research News | More evidence for disparities in the prevalence of COVID-19 across racial/ethnic subgroups, different types of detectable antibody responses tell different stories, potential cause for the loss of smell, and a transmission-humidity link. Plus, vaccine trials in South Africa, and launch of phage-based vaccines.
Full story
-
Aug 19, 2020, 17:22
by
User Not Found
Clinical Research News| The Food and Drug Administration released its nonbinding recommendations for civil money penalties relating to the data submitted to ClinicalTrials.gov earlier this week. They outlined how they plan to identify parties that have failed to submit required clinical trial registration or results information, what the investigation and notification process will be, and what civil money penalties may be assessed and when.
Full story
-
Aug 19, 2020, 10:49
by
BioAegis partners with EastHORN Clinical Services on COVID-19 Program
Full story
-
Aug 19, 2020, 10:49
by
ANA Therapeutics and Quotient Sciences today announced a partnership to support the manufacturing of ANA Therapeutics’ drug candidate, ANA001 (niclosamide capsules), which they are developing as a potential treatment for COVID-19. As part of the collaboration, Quotient will scale up the capsule formulation, characterize and optimize the manufacturing process and ensure continuity of drug product through clinical trials.
Full story
-
Aug 19, 2020, 10:38
by
As a novel strategy for treatment of tumors, oncolytic virotherapy attracts many attention from global researchers. As a world-leading expert in the field of oncolytic virus, Creative Biolabs has executed every strategy to optimize its virus construction services.
Full story
-
Aug 19, 2020, 10:38
by
Innovative Technology and Service Provider Receives Additional $50 Million Capital Commitment from Water Street and JLL Partners
Full story
-
Aug 19, 2020, 10:38
by
As an established drug delivery company focusing on the development and production of drug delivery systems, CD Bioparticles has released a variety of bioactive matrixes covering reagents&assays, responsive hydrogels, functional biomatrixes and photocrosslinkable kits.
Full story
-
Aug 19, 2020, 10:38
by
BioIVT now provides same-day or next-day global delivery of fresh blood and immune cell products from its seven blood donor centers located in the US and UK.
Full story
-
Aug 19, 2020, 10:38
by
As an expert in AI-assisted drug discovery, AI & Medicine recently announces to provide chemical drug development service for researchers worldwide. The powerful AI-assisted drug discovery platform independently developed by this company has already been adopted by a few pharmaceutical companies in their drug R&D endeavors of innovative therapies.
Full story
-
Aug 19, 2020, 10:38
by
To better meet the ever-increasing demand for catalysts in the market, Alfa Chemistry Catalysts is founded and specialized in providing various categories of catalysts, including chiral catalysts, ligands, metal catalysts, non-metal catalysts, organocatalysts, phase transfer catalysts, photocatalysts, and reaction type.
Full story
-
Aug 19, 2020, 10:32
by
Based on the leading CellRapeuticsTM CAR technology platform, Creative Biolabs has optimized the CAR design and construction services, especially for CAR-T therapy and CAR-NK therapy.
Full story
-
Aug 19, 2020, 10:32
by
Creative Diagnostics has released high-quality magnetic silica particles for the isolation of nucleic acid (DNA, RNA) as well as large versus small fragments from various kinds of body fluids, which just takes 3 seconds for complete separation.
Full story
-
Aug 19, 2020, 10:32
by
Australian clinical-stage drug development company Noxopharm is pleased to announce peer-reviewed publication of research showing that in late-stage prostate cancer patients who have exhausted all standard treatment options, a combination of 177Lu-PSMA-617 and Veyonda® is both safe and delivered promising efficacy outcomes, among them a median overall survival of 17.1 months.
Full story
-
Aug 19, 2020, 10:32
by
Full story
-
Aug 14, 2020, 16:45
by
User Not Found
Clinical Research News Brief | A new study from UC Berkeley and the University of Chicago suggests that women are more likely to suffer adverse side effects of medications than men, highlighting a disparity of representation in clinical trials.
Full story
-
Aug 14, 2020, 04:51
by
User Not Found
Clinical Research News | Vaccine updates—both research and commercial, a new drug combo being tested for treatment, and a spotlight on the racial disparity in COVID-19 trials and impacts. Plus, mAbs on trial.
Full story